Trial Site Detail

 

Drug:
Regorafenib (BAY 73-4506)
Trial:
Study of Regorafenib as a 3rd-line or Greater Treatment for Gastrointestinal Stromal Tumors (GIST) (GRID)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Ongoing, but not recruiting

 

Kumamoto University Hospital

     
Kumamoto , 860-8556
Japan

 

Principal Investigator:
Hideo Baba
Contact:
Activation Status of this Site:
Closed
Notes about this Site:
Kumamoto University Hospital Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.